Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jinming Yu

Showing results (151-160 of 821) with videos related to

Pageof 83
Sort By:
Cancer Letters|January 9, 2018
Interactions between EGFR and PD-1/PD-L1 pathway: Implications for treatment of NSCLCXue Li, Zhen Lian, Shuai Wang, et al.
Cancer Science|October 7, 2021
Prediction of the effects of radiation therapy in esophageal cancer using diffusion and perfusion MRIPeiliang Wang, Xin Wang, Liang Xu, et al.
Translational Cancer Research|February 4, 2022
Lymphocyte-monocyte ratio as a predictive marker for pathological complete response to neoadjuvant therapy in esophageal squamous cell carcinomaKewei Zhao, Chunsheng Wang, Fang Shi, et al.
Cancer Biology & Therapy|September 26, 2018
A 4-month-old boy with gastrointestinal stromal tumor of mesocolonXuquan Jing, Xue Meng, Yongsheng Gao, et al.
Oncology Letters|June 20, 2014
Prognostic significance of epidermal growth factor receptor in locally advanced esophageal squamous cell carcinoma for patients receiving chemoradiotherapyZhenhua Gao, Xue Meng, Dianbin Mu, et al.
Frontiers in Immunology|November 7, 2022
Tumor metabolic and secondary lymphoid organ metabolic markers on 18F-fludeoxyglucose positron emission tomography predict prognosis of immune checkpoint inhibitors in advanced lung cancerPeng Jin, Menglin Bai, Jie Liu, et al.
Therapeutic Advances in Medical Oncology|October 6, 2025
Temporal trends in treatment-related cardiopulmonary disease-specific mortality in NSCLC based on pathological subtypes: a retrospective population-based cohort studyYou Mo, Xinyi Liang, Duncan Wei, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 8, 2024
A glutamine tug-of-war between cancer and immune cells: recent advances in unraveling the ongoing battleBolin Wang, Jinli Pei, Shengnan Xu, et al.
Cancer Biology & Medicine|February 6, 2024
Chemotherapy-free radiotherapy combined with immune checkpoint inhibitors: a new regimen for locally advanced non-small cell lung cancer?Lin Ma, Liufu Deng, Jianfeng Peng, et al.
Journal of Cancer Research and Clinical Oncology|March 13, 2026
Efficacy and safety of neoadjuvant chemoimmunotherapy versus neoadjuvant chemoradiotherapy in locally advanced resectable esophageal squamous cell carcinomaYuanyuan Jiang, Zijie Wu, Wei Wang, et al.
Pageof 83

Showing results (151-160 of 821) with videos related to

Sort By:
Pageof 83
Cancer Letters|January 9, 2018
Interactions between EGFR and PD-1/PD-L1 pathway: Implications for treatment of NSCLCXue Li, Zhen Lian, Shuai Wang, et al.
Cancer Science|October 7, 2021
Prediction of the effects of radiation therapy in esophageal cancer using diffusion and perfusion MRIPeiliang Wang, Xin Wang, Liang Xu, et al.
Translational Cancer Research|February 4, 2022
Lymphocyte-monocyte ratio as a predictive marker for pathological complete response to neoadjuvant therapy in esophageal squamous cell carcinomaKewei Zhao, Chunsheng Wang, Fang Shi, et al.
Cancer Biology & Therapy|September 26, 2018
A 4-month-old boy with gastrointestinal stromal tumor of mesocolonXuquan Jing, Xue Meng, Yongsheng Gao, et al.
Oncology Letters|June 20, 2014
Prognostic significance of epidermal growth factor receptor in locally advanced esophageal squamous cell carcinoma for patients receiving chemoradiotherapyZhenhua Gao, Xue Meng, Dianbin Mu, et al.
Frontiers in Immunology|November 7, 2022
Tumor metabolic and secondary lymphoid organ metabolic markers on 18F-fludeoxyglucose positron emission tomography predict prognosis of immune checkpoint inhibitors in advanced lung cancerPeng Jin, Menglin Bai, Jie Liu, et al.
Therapeutic Advances in Medical Oncology|October 6, 2025
Temporal trends in treatment-related cardiopulmonary disease-specific mortality in NSCLC based on pathological subtypes: a retrospective population-based cohort studyYou Mo, Xinyi Liang, Duncan Wei, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 8, 2024
A glutamine tug-of-war between cancer and immune cells: recent advances in unraveling the ongoing battleBolin Wang, Jinli Pei, Shengnan Xu, et al.
Cancer Biology & Medicine|February 6, 2024
Chemotherapy-free radiotherapy combined with immune checkpoint inhibitors: a new regimen for locally advanced non-small cell lung cancer?Lin Ma, Liufu Deng, Jianfeng Peng, et al.
Journal of Cancer Research and Clinical Oncology|March 13, 2026
Efficacy and safety of neoadjuvant chemoimmunotherapy versus neoadjuvant chemoradiotherapy in locally advanced resectable esophageal squamous cell carcinomaYuanyuan Jiang, Zijie Wu, Wei Wang, et al.
Pageof 83